Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Atracurium (25mg/2.5ml) Injection
Therapeutic Category
Antispasmodic, Cardiology
Dosage Form
Injection
Packaging Type
Vial
Packaging
25mg
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Atraxyn 25 Injection contains Atracurium (25mg/2.5ml), a neuromuscular blocking agent used during surgical and intensive care procedures to facilitate muscle relaxation and ease of intubation. It acts by blocking the transmission of nerve impulses to muscles, ensuring controlled muscle relaxation during anesthesia. This injection plays a vital role in the anesthesia and critical care segment, making it an essential product for hospital supply, institutional tenders, and PCD pharma franchise portfolios.
Possible side effects include hypotension, flushing, mild skin rash, or temporary tachycardia. Rarely, severe allergic reactions or bronchospasm may occur.
Indicated for muscle relaxation during general anesthesia, surgical procedures, or mechanical ventilation in intensive care. It is commonly used in operating rooms and ICU settings.
To be administered only by trained healthcare professionals in a controlled medical environment. Continuous monitoring of respiratory and cardiovascular function is essential during use. Inform your doctor of any history of allergies, asthma, or heart problems.
Store in a cool, dry place below 25°C, protected from light. Keep out of reach of children. Do not use if the solution is discolored or contains particles. Use immediately after opening or as instructed by medical personnel.
Composition : Atracurium (10mg) Injection
Composition : Thiocolchicoside (4mg) Capsule
Composition : Thiocolchicoside (4mg) Injection
Composition : Aceclofenac (100mg) + Paracetamol (325mg) + Chlorzoxazone (250mg) Tablet
Composition : Drotaverine (80mg) + Aceclofenac (100mg) Tablet
Composition : Aceclofenac (100mg) + Thiocolchicoside (4mg) Tablet
Composition : Aceclofenac (100mg) + Thiocolchicoside (8mg) Tablet
Composition : Baclofen (10mg) Tablet
Composition : Baclofen (20mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Atracurium Injection has strong demand in the anesthesiology and critical care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on hospital, surgical, and ICU portfolios.
Medical distributors and agencies can benefit from consistent hospital demand for use in general anesthesia during surgery, muscle relaxation during intubation, and ICU ventilator management support. Atracurium is a fast-acting neuromuscular blocker widely used in operation theatres, strengthening a reliable hospital injectable portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Atracurium 25mg/2.5ml Injection with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong hospital and surgical demand, ICU usage, bulk institutional orders, fast-moving critical care category, reliable supply chain support, and good margins when partnering for this anesthesia product.
Medical distributors, stockists, and wholesalers interested in Atracurium Injection can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, pricing, regulatory requirements, and distribution support.